Medtronic plc’s Arctic Front cardiac cryoablation system is the first cardiac ablation device approved by the US Food and Drug Administration for “first-line” treatment of symptomatic paroxysmal (occasional) atrial fibrillation, the agency announced on 21 June.
The FDA approved a PMA supplement to expand Arctic Front’s indications to include the treatment of recurrent symptomatic paroxysmal...






